Hjem › Makuladegenerasjon › Ohio
Kliniske studier for Makuladegenerasjon i Ohio
11 studier for Makuladegenerasjon søker deltakere på steder i Ohio.
Byer i Ohio
Offisiell studietekst (engelsk)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Cincinnati Eye Institute (Site 133), Cincinnati
RekruttererFase 2/3
Alder 50 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Cincinnati Eye Institute, Cincinnati
- Cleveland Clinic Main Campus, Cleveland
RekruttererFase 2/3
Alder 60 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Retina Associates of Cleveland - Beachwood, Beachwood
- Retina Associates of Cleveland, Cleveland
- Retina Associates of Cleveland - Middleburg Heights, Middleburg Heights
RekruttererFase 1/2
Alder 55 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07029945A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Cincinnati Eye Institute, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- The Ohio State University, Columbus
- og 1 flere
RekruttererFase 3
Alder 50 til 85 · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06541704A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
- Cincinnati Eye Institute, Cincinnati
RekruttererFase 1
Alder 6 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07734064Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Cleveland Clinic Foundation-Cole Eye Institute, Cleveland
RekruttererFase 2
Alder 55 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06659445Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.
- Cleveland Clinic, Cleveland
RekruttererObservasjonsstudie
Alder 50 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07798323Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- Retina Associates of Cleveland, Beachwood
Rekrutterer
Alder 60 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Cincinnati Eye Institute, Cincinnati
RekruttererObservasjonsstudie
Alder 6 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT07425574Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Cincinnati Eye Institute, Cincinnati
RekruttererFase 3
Alder 50 og eldre · Alle kjønn · Oppdatert 16. apr. 2026 · NCT07064759Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Cleveland Clinic | Cole Eye Institute, Cleveland
Rekrutterer
Alder 65 og eldre · Alle kjønn · Oppdatert 3. des. 2024 · NCT05438732Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.